Novel biology is the key to discovery, and metabolomics enables scalable measure of varied functional metabolic states in humans.
On closing the gap between molecular measurement & clinical meaning, rapidly extracting actionable biological signals.
Discovering novel functional markers that capture tumor biology, TME interactions, and drug response/resistance in archived tissue.
Going beyond IHC to, for the first time, directly quantify the functional protein landscape of tumors in FFPE samples.
PharmaShots delves into Sapient’s mission to transform multi-omics research through innovation & world-class partnerships.
Extending molecular insights beyond DNA and RNA to realize new value in existing FFPE tissue biobanks.
A look at how AI-driven, multi-omics platforms are advancing the discovery and development of precision medicines.
Unlocking functional biology, new biomarker insights, and responder profiles from archived trial samples.
Using TAA profiling to identify differentially expressed, disease-modifying, tractable targets on the cell surface.
Delivering quantitative, reproducible protein measures for rapid proof-of-mechanism & target engagement insights.
Using multi-omics to characterize changes in inflammatory markers observed following GLP-1 therapy.
Transforming archival tissue into a discovery-ready resource to move from target discovery to functional validation, in weeks.
